@techcrunch.com 6 years ago
Fractyl Labs raises $44 million in Series D to develop a treatment for type 2 diabetes
@techcrunch.com 9 years ago
Amid ‘Right To Try’ Debate, myTomorrows Raises €4.5M To Give Patients Access To Development-Stage Drugs